CervoMed Inc. Share Price & Technical Analysis
CRVO · $3.06 (-0.97%)
Healthcare / Biotechnology
$3.06
-0.97%
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slo…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-16% return in May, -15% avg return in past 3 year May month.
-82% return in 2026, 123% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -35% | -23% | 0% | -7% | -16% | – | – | – | – | – | – | – | -82% |
| 25 | -4% | 0% | 314% | 1% | -22% | -12% | 32% | 19% | -16% | -12% | 41% | -19% | 322% |
| 24 | 12% | 57% | 71% | 13% | -22% | -17% | -24% | 43% | -21% | -7% | -22% | -82% | 3% |
| 23 | 30% | -13% | -29% | -6% | 0% | -11% | -6% | 28% | -21% | 87% | 8% | -23% | 44% |
| 22 | -13% | -18% | 9% | -52% | 32% | -19% | -2% | 5% | -18% | -9% | 32% | -19% | -71% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$35.09M
P/E ratio
—
52W high
$13.13
52W low
$2.82
Volume
1,02,022
Beta
-4.47
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is CervoMed Inc. share price today?
- CervoMed Inc. (CRVO) last traded around $3.06 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CRVO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CRVO. Download the app for real-time alerts.
- How can I analyze CervoMed Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.